GAPDH and cancer: To test the strategy of therapeutically targeting the alkaline pHi preference of cancer cells, experiments were designed to first decrease the pHi by blocking lactate transporters and then inhibit the leading selective and pH-specific targets, GAPDH and GPI (Fig. 3, Methods, and Supplementary Figures 13–16).